APEX | The Current State of Play on MFN: Skepticism on Administrative Execution, Attention Around Congressional Action
Shares:
Most days, I want this newsletter to serve as an opportunity to pause and meaningfully chew on the issues of the day. To layer in context and nuance and snark.
Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv
One of the most important needs in the biopharma industry is communicators who can make the case not only for innovation but also for the broader policy and business environment